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Summary
Composition of follicular fluid is also regarded to be linked to quality of oocytes, fertilization 
and quality of the embryo. The aim of this study was to investigate the concentration of IL-18 
and IL18BP in follicular fluid (FF) in a homogeneous group of women with sterility caused by 
“tubal factor” subjected to in vitro fertilization (IVF) and the relation between concentrate of 
this cytokine and IVF outcome.
The study group consisted of 83 non-smoking women aged 30.9 ± 3.2 (23.0–43.0) with confirmed 
(hysterosalpingography and/or laparoscopy) bilateral complete tubal impermeability. Follicu-
lar fluid levels of IL-18 and IL18BP were evaluated in 83 patients undergoing in vitro fertilization 
(IVF). Ovarian hormonal stimulation was conducted according to a GnRH antagonist protocol. 
The measurement of IL-18 and IL18BP in follicular fluid was done using the ELISA method. 
The mean follicular levels of IL-18 and IL18BP were 468.5 ± 357.4 pg/ml and 8611.3 ± 534 pg/
ml. The biochemical pregnancy rate was 39.7% (33/83); 22 women became clinically pregnant 
(26.5%). The implantation rate was 26.7% (36/135). No significant correlation was found be-
tween follicular concentrations of IL-18 and age of the patients (r=0.13 p>0.05), number of 
metaphase II oocytes collected (r=-0.11 p>0.05), number of 3-day embryos (r=-0.157 p>0.05), 
biochemical pregnancies (r=0.03 p>0.05), or clinical pregnancies (r=-0.06 p>0.05). Also there 
was no significant correlation between IL18BP and age of the patients (r=0.21 p>0.05), number 
of metaphase II oocytes collected (r=0.08 p>0.05), number of 3-day embryos (r=-0.19 p>0.05), 
biochemical pregnancies (r=0.11 p>0.05) and clinical pregnancies (r=-0.34 p>0.05).
IL-18 and IL18BP are detectable in follicular fluid but do not determine IVF outcome in women 
with “tubal factor”. IL-18 and IL18BP are not promising prognostic markers for IVF success 
in this subgroup of patients.
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IntroductIon
The immuno-endocrine network seems to be responsible 
for both female reproductive success and failure; howev-
er, the role of precise cytokine regulation in reproduction 
is still far from a definite solution. Follicular fluid contains 
factors responsible for oocyte maturation and ovulation; 
therefore some disturbances of its composition may af-
fect folliculogenesis [5,11,15,21] . The presence of many 
pro-inflammatory and immuno-regulatory cytokines, as 
well as growth factors, was confirmed in follicular fluid 
including interleukins (IL-1β, IL-2, IL-6, IL-8, IL-12, IL-18), 
tumor necrosis factor (TNF)-α, interferons (IFNs), leuke-
mia inhibitory factor (LIF), epidermal growth factor (EGF), 
vascular endothelial growth factor (VEGF), macrophage 
colony-stimulating factor (M-CSF), macrophage chemoat-
tractant protein-1 (MCP-1) and granulocyte-macrophage 
colony-stimulating factor (GM-CSF), suggesting their role 
in oocyte development, ovulation and regulation of oo-
cyte quality. The results of these investigations have pro-
vided the background for research on the influence of 
cytokines on the reproductive outcome during IVF cycles. 
The studies were mostly concentrated on the cytokine 
concentrations in both patients’ serum and follicular flu-
id, and so far have given inconsistent results [2,4,5,6,8, 
10,11,13,15,17,18,21].
Interleukin 18 (IL-18) is a cytokine that belongs to the IL-
1-superfamily. Although initially thought to be produced 
mainly by macrophages and adipocytes, now it has been 
found that IL-18 mRNA is expressed in a variety of cells 
including Kupffer cells, T and B cells, osteoblasts and den-
dritic cells [19]. IL-18 was believed to be an exclusively 
pro-inflammatory cytokine able to induce strong Th1 re-
sponses in immunocompetent cells, to activate NK cells’ 
and T lymphocytes’ killing properties, and to up-regulate 
the expression of chemokine receptors [24] . Its function 
was indicated in host defense against severe bacterial, fun-
gal, viral and protozoal infections, as well as in tumor re-
jection. However, recent studies have revealed that IL-18 
could also function as a Th2 stimulant. This bidirectional 
IL-18 activity for naïve T cells depends on the cytokine mi-
croenvironment, and in the presence of IL-12 shifts them 
towards IFNg-producing Th1 cells, while upon IL-2 stimu-
lation it augments IL-4 and IL-13-secreting Th2 lympho-
cytes [27,28]. The biological functions of IL-18 are mediated 
through its receptor (IL-18R). IL-18R resembles IL-1R and 
shares with it a signal-transduction pathway [1]. Expres-
sion of IL-18R was confirmed on both Th1 lymphocytes and 
NK cells, whereas it was not observed on Th2 lymphocytes 
[17]. The interaction between IL-18R and its ligand could be 
modified by the presence of IL-18 binding protein (IL18BP), 
which blocks the binding of IL-18 to IL-18R. IL18BP mRNA 
is expressed constitutively in various tissues, and may act 
as a soluble decoy receptor [20,23].
Expression of both IL-18 and IL-18R was found in the ova-
ries of pregnant mice [23]. IL-18 has been suggested to 
favor ovarian folliculogenesis [15,21]. Inactivation of IL-
18R with murine monoclonal antibody during ovarian 
stimulation reduced the number of ovulated oocytes and 
inhibited the expansion of cumulus cells surrounding 
the ovum [23]. Significantly higher IL-18 levels were also 
detected in serum and peritoneal fluid of patients with 
severe ovarian hyperstimulation syndrome [3]. Further-
more, higher follicular IL-18 concentration was correlat-
ed positively with the chance for successful pregnancy, 
whereas lower levels of IL-18 were found in women with 
idiopathic infertility [22].
In the opinion of some authors, increased concentration 
of IL-18 might be a promising prognostic marker for IVF 
success [16,22]. 
The aim of this study was to investigate the concentration 
of IL-18 and IL18BP in follicular fluid in a homogeneous 
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group of women with sterility caused by “tubal factor” 
subjected to in vitro fertilization (IVF). 
MaterIal and Methods
Patient selection and ovarian stimulation
The study group consisted of 83 non-smoking women 
aged 30.9 ± 3.2 (23.0–43.0) with confirmed (hysterosalpin-
gography and/or laparoscopy) bilateral complete tubal 
impermeability (so-called “tubal factor”) admitted to the 
Division of Reproductive Medicine of “Gameta Hospi-
tal”, Lodz, Poland, and evaluated prospectively between 
2009 and 2010. The Local Ethics Committee on Human 
Research approved this study, and informed consent was 
obtained from all patients. Semen samples obtained from 
the male partners were examined according to World 
Health Organization criteria, and women having partners 
with impaired sperm parameters were excluded from the 
trial. All included couples were administered 1 gram of 
azithromycin one month before ovarian stimulation. The 
results of serological and microbiological assays (bacte-
rial vaginosis, Chlamydia trachomatis, hepatitis B and C, 
toxoplasmosis, cytomegalovirus infection, human im-
munodeficiency virus, lues), as well as routine laboratory 
tests (leukocytosis, sedimentation rate, serum C-reactive 
protein) performed just before IVF did not reveal signs 
of any infection. 
Ovarian hormonal stimulation was conducted accord-
ing to a protocol of gonadotrophin-releasing hormone 
(GnRH) antagonist (Cetrotide; Merck Serono, Geneva, 
Switzerland) 0.25 mg daily commenced on stimulation 
day 6 until the end of stimulation, administered with 
recombinant follicle-stimulating hormone (rFSH) (Go-
nal-F; Merck Serono, Geneva, Switzerland) 150 IU given 
once daily subcutaneously (so-called “short antagonist 
protocol”). Recombinant human chorionic gonadotropin 
(rhCG) (Ovitrelle, Merck-Serono, Geneva, Switzerland) 
250 μg subcutaneously was administered when at least 
three follicles having 18 mm diameter each were visual-
ized using trans-vaginal ultrasound. The oocyte pick-up 
was scheduled 36 h later.
Assessment of oocyte maturity, ICSI and embryo 
culture
Within 3 hours after oocyte pick-up both the cumulus 
oophorus and the corona radiata were removed from oo-
cytes using micropipette manipulation after 20 s incuba-
tion in a solution of 40 IU/ml hyaluronidase (Hyase, Vi-
trolife, Göteborg, Sweden) carried out at 37°C. Denuded 
oocytes were assessed for maturity. Only mature meta-
phase II oocytes identified by the presence of the first 
polar body were fertilized. All patients had a standard 
intra-cytoplasmic sperm injection (ICSI) procedure per-
formed, using commercially available culture media (Vi-
trolife, Göteborg, Sweden) in a multi-dish under mineral 
oil. Oocytes and embryos were cultured in an incubator at 
37°C in humid atmosphere containing 6% CO2, 5% O2 and 
89% N2. Embryo development was evaluated 3 days after 
fertilization and good-quality embryos were identified by 
the presence of at least four blastomeres and low frag-
mentation rate (<20%). The two best quality embryos were 
transferred for every patient. Biochemical pregnancy was 
assessed based on the serum hCG on the 10th day after 
the embryo transfer. Clinical pregnancy was confirmed 
by the presence of a gestational sac 30 days after blasto-
cyst transfer [29]. The basic characteristics of the study 
group are presented in Table 1. 
Follicular fluid collection and cytokine assay
Follicular fluid (FF) was collected from all matured fol-
licles (>18 mm of mean diameter) during ovarian pick-up 
(OPU) and then centrifuged at 3000g for 15 minutes to 
eliminate cells and debris. Supernatant was separated 
and stored at –20°C until the levels of IL-18 and IL18BP 
were evaluated. The measurement of IL-18 and IL18BP 
in follicular fluid was done using commercially available 
ELISA kits provided by Medical & Biological Laborato-
ries Co (Nagoya, Japan) and R&D Systems (Minneapo-
lis, USA) respectively. All samples were thawed at one 
time, tested in triplicate and the results were expressed 
as the mean ± standard deviation (SD). The absorbance 
was read at 450 nm and 620 nm (reference wavelength). 
The detection limits were 12.5 pg/mL for IL-18 and 1.6 
pg/mL for IL18BP.
statIstIcal analysIs
Data were analyzed for normality of distribution using the 
Shapiro–Wilk test. The statistical analysis was performed 
using unpaired Student’s t-test, Mann-Whitney U test and 
Spearman test for correlation analysis. 
results
The mean follicular level of IL-18 and IL18BP was 468.5 
± 367.4 pg/ml and 8611.3 ± 533.9 pg/ml respectively. The 
number of mature metaphase II oocytes was 9.3 ± 6.1, 
and the number of good-quality 3-day embryos was 5.2 ± 
3.6 (Table 1). The biochemical pregnancy rate was 39.7% 
(33/83) whereas 22 women (26.5%) became clinically 
pregnant. On day 3 431 cleavage embryos were obtained 
and 184 (42%) of them were “top quality” grade A em-
bryos (Table 1). Eighty-three embryo transfers were per-
formed and 135 embryos were transferred. The implan-
tation rate was 26.7% (36/135). 
We did not find any significant difference in the number 
of MII oocytes and 3-day embryos, or the FF concentration 
of IL-18 and IL-18BP, between the group of 22 woman who 
achieved and the group of 61 women who failed to achieve 
biochemical and clinical pregnancy (Tables 2 and 3).
Considering the implantation rate, no significant differ-
ence was found in concentration of IL-18 or IL-18BP in 
the group of patients with positive and negative implan-
tation (Table 4).  
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Although there was a weak negative correlation between 
the concentration of IL-18 and IL-18 BP in FF, it was found 
to be insignificant (Figure 1). There was no significant 
correlation between IL-18 and IL18BP and positive hCG 
level ten days after embryo transfer (r =-0.270 p>0.05 
and r =-0.124 p>0.05 respectively). No significant corre-
lation was also found between follicular concentrations 
of IL-18 and age of the patients (r=0.13 p>0.05), number 
of metaphase II oocytes collected (r=-0.11 >0.05), number 
Table 1.  Follicular fluid IL-18 and IL18-BD concentrations, age, number of MII oocytes , number of 3-day embryos, number of grade A embryos and value of positive 
hCG in study group
No. of Patients n=83 Mean value Minimum value Maximum value SD
IL18 [pg/mL] 468.5 115.5 2133.7 367.4
IL18BP [pg/mL] 8611.3 7621.7 9907.4 533.9
Age  30.9 23.0 43.0 3.2
MII oocytes 9.3 1.0 31.0 6.1
Number of 3-day embryos
(n=431) 
5.2 0.0 15.0 3.6
Number of top quality (grade A) embryos in day 
3 (n=184)
2.2 1 5 1.1
Positive hcg level 10 days after ET [mlU/ml]
(n=33)
88.3 34 180 30.2
of 3-day embryos (r=-0.157 p>0.05), biochemical preg-
nancies (r=0.03 p>0.05), or clinical pregnancies (r=-0.06 
p>0.05). Also there was no significant correlation between 
IL18BP and age of the patients (r=0.21 p>0.05), number of 
metaphase II oocytes collected (r=0.08 >0.05), number of 
3-day embryos (r=-0.19 p>0.05), biochemical pregnancies 
(r=0.11 p>0.05), clinical pregnancies (r=-0.34 p>0.05) or 
implantation rate (r=-0.19 p>0.05). 
Table 2 .  Follicular fluid IL-18 and IL18-BD concentrations, age, number of M II oocytes, number of 3-day embryos and grade A embryos in the group of women with 
clinical pregnancy compared to the group of women without clinical pregnancy
Clinical pregnancy Age MII
Number of 
3-day embryos
Number of top quality 
(grade A) embryos in 
day 3
IL-18 IL-18BP
Yes
n= 22
30.2 ± 3.2 10.1±5,3 6.1±3.5 2.6±1.3 413.7±381.3 8703.9± 539.2
No
n=61
31.2 ± 3.0 9±6.4 4.8±3.5 2.0 ±1 488.3±327.4 8577.8±532.5
P ns ns ns P<0.05 ns ns
Table 3.  Follicular fluid IL-18 and IL18-BD concentrations, age, number of MII oocytes, number of 3-day embryos and grade A embryos in the group of women with 
biochemical pregnancy compared to the group of women without biochemical pregnancy
Biochemical
Pregnancy
Age MII
Number of 
3-day embryos
Number of top quali-
ty (grade A) embryos 
in day 3
IL-18 IL-18BP
Yes
n= 33
30.1 ± 3.1
9.5±6.8 5.2 ±3.3 2.4±1.2 455.7±314 8685.8± 526.3
No
n=56
31.1 ± 2.9 9± 4.9 5.1 ±3.2 2.0±1.1 479.3±390 8562.1,8±526.3
P  ns ns ns ns ns ns  
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Table 4.  Follicular fluid IL-18 and IL18-BD concentrations, age, number of MII oocytes, number of 3-day embryos and grade A embryos in the group of women with 
successful implantation compared to the group of women without implantation
No of embryos im-
planted
Age MII
Number of 
3-day embryos
Number of top quali-
ty (grade A) embryos 
in day 3
IL-18 IL-18BP
Yes
36/135 (26.7%)
30.2±3 8.6±5 4.6 ±3.1 3.2±1.0 420.7±390 8712± 544
No
99/135 (73.3%)
31.6±3.2 9.5±6.7 5.2 ±3.7 2.4 ±1.25 490 ±340 8553 ±544
P  ns ns ns ns ns  ns
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Fig. 1. Correlation between the level of IL-18 and IL18BP in follicular fluid
Fig. 2. Correlation between the positive level of hCG in serum and IL-18 in follicular fluid  
       -               -               -               -               -       468
Postepy Hig Med Dosw (online), 2013; tom 67: 463-470
dIscussIon
Only a few studies have investigated a possible relation-
ship of IL-18 with IVF outcome. To our knowledge, our 
study is the first one to investigate both IL-18 and IL18BP 
in follicular fluid in patients with tubal factor infertility 
stimulated using a “short antagonist protocol”. 
Cytokines inside the ovary seem to be important modi-
fiers of follicular growth and ovulation. The presence of 
considerable amounts of IL-18 in follicular fluid observed 
in our study suggests its role in follicular growth and mat-
uration. This suggestion is supported by results obtained 
by Sarapik et al., who showed that IL-18 was positively 
correlated with follicle growth [22]. However, IL-18 during 
reproduction has many faces. Detectable levels of IL-18 
were found not only in follicular fluid, but also in uter-
ine luminal secretions and patient’s serum [12,15,25,26]. 
Increased level of uterine IL-18 was correlated with de-
creased uterine receptivity and low pregnancy rate. Simi-
larly, IL-18 serum concentration was shown to be higher 
in women with recurrent miscarriage and was correlated 
with pregnancy loss [26]. The observed follicular fluid or 
serum levels of IL-18 also depended on the kind of pathol-
ogy of the female reproductive tract including endome-
triosis, polycystic ovarian syndrome (PCOS), and ovarian 
hyperstimulation syndrome (OHSS) [9].
According to some observations, concentrations of IL-18 
could serve as a prognostic factor of both reproductive 
success and failure. Detectable levels of interleukin-18 
in uterine secretions at the time of oocyte retrieval pre-
dicted failure of the IVF procedure in the study of Ledee-
Bataille et al. [16]. The group of patients positive for IL-
18 had a significantly lower pregnancy rate, multiple 
pregnancy rate and implantation rate as well. Follicular 
fluid IL-18 at the time of oocyte retrieval was positively 
correlated with the number of oocytes and predicted the 
development of OHSS in high responders [7,9]. A simi-
lar conclusion was presented by Barak et al., who found 
that significantly higher IL-18 levels were detected in 
serum and peritoneal and pleural fluids of patients with 
severe OHSS as compared with a control group [3]. The 
recent study of Sarapik et al. showed a significant posi-
tive correlation between follicular IL-18 levels and in-
creased chance for intrauterine pregnancy, number of 
fetuses detected by ultrasonography and with increased 
parity [22]. However, our data neither confirmed any 
correlation between IL-18 concentration and pregnancy 
outcome in the group of infertile women with “tubal 
factor” subjected to the IVF procedure, nor showed any 
correlation of IL-18 with the number of mature MII oo-
cytes and good-quality embryos. Lack of a correlation 
of intrafollicular IL-18, IL-18BP, and the IL-18/IL-18BP 
ratios with the number of oocytes retrieved and trans-
ferred, embryo grades or pregnancy ratios was observed 
in obese, overweight, and non-obese patients by Kilic et 
al. [12], supporting our observations. The Sarapik et al. 
study was performed on a heterogenic group of infertile 
patients (tubal factor infertility, PCOS, endometriosis, 
unexplained infertility), and the authors collected the 
greatest group of patients from couples with exclusively 
male infertility [22]. In contrast, our group of patients 
was homogeneous according to the reason for infertil-
ity, which was the strength of our study. Moreover, the 
methodology of evaluation of follicular fluid samples 
differed in both studies. It was shown that the assay 
used for quantification of cytokine in follicular fluid 
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Fig. 3. Correlation between the positive level of hCG in serum and IL18BP in follicular fluid
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might influence the final result [14]. Use of an ELISA as-
say might be considered in this context as a weakness 
of our study. Moreover, the results of different studies 
could be hardly comparable due to the different stimu-
lation protocols used. In spontaneous cycles, values of 
IL-18 in follicular fluid are lower (38.2± 25.1–50.2 pg/ml) 
than during stimulation [25]. In the study of Gutman et 
al. [9] all women were stimulated using GnRH agonist 
in a so-called “long protocol”. The mean level of IL-18 
was lower in comparison to our study (228± 208 pg/
ml vs. 468.5 ±357.4 pg/ml). The probability that type of 
ovarian stimulation influences and modifies cytokine 
synthesis in follicular fluid including IL-18 cannot be 
rationally excluded.
IL-18 binding protein is regarded as a natural inhibitor 
of IL-18 activity. We found that a negative correlation 
did exist between IL-18 and IL18BP concentrations in 
follicular fluid, but it was insignificant. Therefore, it 
is probably not IL18BP that is mainly responsible for 
regulation of IL-18 inside the growing follicle. The role 
of different cytokines in this process still needs further 
elucidation. 
In conclusion, IL-18 and IL18BP are detectable in follicu-
lar fluid but do not determine IVF outcome in women 
with “tubal factor”. IL-18 and IL18BP do not seem to be 
promising prognostic markers for IVF success in this sub-
group of patients. 
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